Pacira BioSciences (PCRX) Acquisitions (2019 - 2026)
Pacira BioSciences (PCRX) recorded quarterly Acquisitions of $335000.0 in Q1 2026, down 97.99% quarter-over-quarter from $16.7 million in Q1 2025, and down 97.99% on a YoY basis from $16.7 million in Q1 2025.
Pacira BioSciences (PCRX) Acquisitions (2019 - 2026) Analysis & Trends
Pacira BioSciences' Acquisitions history runs 3 years deep, the most recent figure standing at $335000.0 for Q1 2026.
- In Q1 2026, Acquisitions fell 97.99% year-over-year to $335000.0; the TTM figure through Mar 2026 stood at $335000.0 (down 97.99% YoY), while the FY2025 annual figure was $16.7 million, changed N/A from the prior year.
- Acquisitions was $335000.0 for Q1 2026 at Pacira BioSciences, down from $16.7 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $16.7 million in Q1 2025 to a low of $335000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.09 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 137.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Pacira BioSciences | 940.31 Mn | 738.13 Mn | 140.96 Mn | 335,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 335,000.00 |
| Mar 31, 2025 | 16.70 Mn |
| Dec 31, 2019 | -992,000.00 |